Cargando…
Emerging safety issues in alemtuzumab-treated MS patients
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681426/ https://www.ncbi.nlm.nih.gov/pubmed/31368417 http://dx.doi.org/10.1177/1352458519851219 |
| _version_ | 1783441729787002880 |
|---|---|
| author | Killestein, Joep van Oosten, Bob |
| author_facet | Killestein, Joep van Oosten, Bob |
| author_sort | Killestein, Joep |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6681426 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-66814262019-09-16 Emerging safety issues in alemtuzumab-treated MS patients Killestein, Joep van Oosten, Bob Mult Scler Editorial SAGE Publications 2019-08-01 2019-08 /pmc/articles/PMC6681426/ /pubmed/31368417 http://dx.doi.org/10.1177/1352458519851219 Text en © The Author(s), 2019 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| spellingShingle | Editorial Killestein, Joep van Oosten, Bob Emerging safety issues in alemtuzumab-treated MS patients |
| title | Emerging safety issues in alemtuzumab-treated MS
patients |
| title_full | Emerging safety issues in alemtuzumab-treated MS
patients |
| title_fullStr | Emerging safety issues in alemtuzumab-treated MS
patients |
| title_full_unstemmed | Emerging safety issues in alemtuzumab-treated MS
patients |
| title_short | Emerging safety issues in alemtuzumab-treated MS
patients |
| title_sort | emerging safety issues in alemtuzumab-treated ms
patients |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681426/ https://www.ncbi.nlm.nih.gov/pubmed/31368417 http://dx.doi.org/10.1177/1352458519851219 |
| work_keys_str_mv | AT killesteinjoep emergingsafetyissuesinalemtuzumabtreatedmspatients AT vanoostenbob emergingsafetyissuesinalemtuzumabtreatedmspatients |